(Reuters) -Swiss drugmaker Idorsia said on Monday it has received the U.S. Food and Drug Administration's approval for its treatment for insomnia in adult patients. The drug, to be available under the ...

Pretty much everyone has heard of sleepwalking – and some of us even do it from time to time. But sleep cooking and sleep driving? Engaging in such activities while not awake – a phenomenon known as ...

The U.S. Food and Drug Administration is asking several drug manufacturers to strengthen product warning labels for many sleep medications because of risks that people will do things they don’t ...

The number of people suffering from insomnia has surged during the pandemic: Twenty-eight percent of Americans, in fact, said they’ve had a harder time falling or staying asleep since its onset, ...

(Reuters) - The U.S. health regulator warned that taking a widely prescribed insomnia drug at night may impair driving and alertness the next morning, and recommended the bedtime dose be lowered. New ...

Persistent sleeplessness stems from a variety of factors, all of which should be addressed if a treatment plan is to succeed long-term. While many patients (10%-40% of the population) complain about ...

A few years ago, drug giant Bristol-Myers Squibb Co. announced it was retooling its strategy, meaning a drug it was developing for insomnia was probably headed for the sidelines. Vanda Pharmaceuticals ...

The U.S. Food and Drug Administration today approved Intermezzo (zolpidem tartrate sublingual tablets) for use as needed to treat insomnia characterized by middle-of-the-night waking followed by ...

ATS 2023, Washington, DC – Chronic obstructive pulmonary disease patients newly prescribed non-benzodiazepine benzodiazepine receptor agonists (NBZRAs) such as zolpidem (Ambien, Intermezzo and other ...

Sept. 27, 2012 -- Seniors who take certain kinds of drugs to treat anxiety or insomnia may be more likely to develop dementia than those who do not, a new study shows. Seniors are often prescribed ...

Two drugs have emerged as the optimal medications for treating insomnia based on the "best-available evidence," but there are caveats. In a comprehensive comparative-effectiveness analysis, ...